| Literature DB >> 36078595 |
Charlotta Pisinger1,2,3, Cecilie Goltermann Toxværd2, Mette Rasmussen4,5.
Abstract
Financial incentives offered to those who quit smoking have been found effective, also in persons with low socioeconomic status (SES), but no previous study has investigated who benefits most: smokers with low or high SES. In this community-randomized trial ("Richer without smoking"), three Danish municipalities were randomized to reward persons who were abstinent when attending the municipal smoking cessation program (FIMs) and three municipalities were randomized to spend the same amount on smoking cessation campaigns recruiting smokers to the smoking cessation program (CAMs). The municipalities each received approximately USD 16,000. An intention-to-treat approach was used in analyses. In regression analyses adjusted for individual- and municipal-level differences, we found that smokers with high SES living in FIMs had significantly higher proportion of validated long-term successful quitters (OR (95% CI): 2.59 (1.6-4.2)) than high-SES smokers living in CAM. Smokers with low SES, however, did not experience the same benefit of financial incentives as smokers with high SES. Neither the FIMs nor the CAMs succeeded in attracting more smokers with low SES during the intervention year 2018 than the year before. Our study showed that smokers with low SES did not experience the same benefit of financial incentives as smokers with high SES.Entities:
Keywords: financial incentives; smoking cessation; socioeconomic status
Mesh:
Year: 2022 PMID: 36078595 PMCID: PMC9518409 DOI: 10.3390/ijerph191710879
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Figure 1Flowchart of the allocation of municipalities and recruitment and follow-up status of smokers included in the community-randomized trial “Richer without smoking”, Denmark.
Baseline characteristics of smokers with high and low socioeconomic status (SES) included in the community-randomized trial “Richer without smoking”, Denmark.
| Characteristics | Financial Incentives | Campaign | ||||||
|---|---|---|---|---|---|---|---|---|
| Low SES | High SES | Low SES | High SES | |||||
| n | % | n | % | n | % | n | % | |
| Total | 137 | 48.1% | 148 | 51.9% | 274 | 48.4% | 292 | 51.6% |
| Sex | ||||||||
| Men | 57 | 41.6% | 59 | 39.9% | 114 | 41.6% | 121 | 41.4% |
| Women | 80 | 58.4% | 89 | 60.1% | 160 | 58.4% | 171 | 58.6% |
| Age | ||||||||
| Up to 24 | 8 | 5.8% | 29 | 10.6% | 12 | 4.1% | ||
| 25–34 | 12 | 8.8% | 12 | 8.1% | 35 | 12.8% | 33 | 11.3% |
| 35–44 | 21 | 15.3% | 21 | 14.2% | 41 | 15.0% | 41 | 14.0% |
| 45–54 | 38 | 27.7% | 30 | 20.3% | 56 | 20.4% | 70 | 24.0% |
| 55–66 | 49 | 35.8% | 42 | 28.4% | 90 | 32.8% | 76 | 26.0% |
| 67+ | 9 | 6.6% | 43 | 29.1% | 23 | 8.4% | 60 | 20.5% |
| Heavy smokers | ||||||||
| No (1–14 cigarettes/day) | 21 | 15.3% | 31 | 20.9% | 71 | 25.9% | 88 | 30.1% |
| Yes (15+ cigarettes/day) | 116 | 84.7% | 117 | 79.1% | 203 | 74.1% | 204 | 69.9% |
| Fagerström score a | ||||||||
| Low (0–6) | 89 | 65.0% | 106 | 71.6% | 169 | 61.7% | 231 | 79.1% |
| High (7–10) | 48 | 35.0% | 42 | 28.4% | 105 | 38.3% | 61 | 20.9% |
| Free/subsidized NRT b | ||||||||
| No | 113 | 82.5% | 99 | 66.9% | 134 | 48.9% | 149 | 51.0% |
| Yes | 24 | 17.5% | 49 | 33.1% | 140 | 51.1% | 143 | 49.0% |
a Nicotine dependence; b NRT: nicotine replacement therapy.
Recruitment of smokers in the FIMs and CAMs in the year of intervention (2018) and the year before (2017). Data are presented according to socioeconomic status (SES).
| Financial Incentives | Campaign | |||||||
|---|---|---|---|---|---|---|---|---|
| 2017 | 2018 | 2017 | 2018 | |||||
| n | % | n | % | n | % | n | % | |
| Socioeconomic status | ||||||||
| Low SES |
| 44.4% | 137 | 48.1% | 146 | 47.9% | 274 | 48.4% |
| High SES |
| 55.6% | 148 | 51.9% | 159 | 52.1% | 292 | 51.6% |
Figure 2Abstinence rates from smoking in the “Richer without smoking” study, based on the intention-to-treat principle; Denmark, 2018. Validated abstinence rates at the end of the intervention (4–6 weeks), after 12+-months, and self-reported abstinence rates after 6 months. FIM: financial incentive municipality, CAM: campaign municipality, SES: socioeconomic status.
Unadjusted and adjusted logistic regression analysis of the effect (successful quitting) in the financial incentives municipalities (FIMs) compared with the campaign municipalities (CAMs) at the end of the intervention, and after 6 and 12+-months. The results are based on the intention-to-treat principle and stratified by socioeconomic status (SES). OR: odds ratio, CI: confidence interval.
| Unadjusted Analyses | Adjusted Analyses | |||||
|---|---|---|---|---|---|---|
| Intervention | OR | [CI 95%] |
| OR | [CI 95%] |
|
| Low SES | ||||||
| CAMs | 1.00 | |||||
| FIMs (4–6 weeks) | 1.77 | [1.16, 2.70] | 0.008 * | 1.16 | [0.62, 2.18] | 0.639 |
| FIMs (6 months) | 1.22 | [0.74, 2.01] | 0.437 | 0.62 | [0.26, 1.45] | 0.268 |
| FIMs (12+-months) | 1.29 | [0.73, 2.28] | 0.375 | 1.17 | [0.55, 2.51] | 0.677 |
| High SES | ||||||
| CAMs | 1.00 | |||||
| FIMs (4–6 weeks) | 1.84 | [1.17, 2.91] | 0.009 * | 1.51 | [0.63, 3.62] | 0.344 |
| FIMs (6 months) | 2.16 | [1.41, 3.30] | ≤0.001 * | 2.35 | [1.21, 4.55] | 0.011 * |
| FIMs (12+-months) | 2.69 | [1.68, 4.33] | ≤0.001 * | 2.59 | [1.59, 4.22] | ≤0.001 * |
Adjusted analyses included age, sex, Fagerström score, number of cigarettes smoked daily, abstinence in 2017, proportion of smokers receiving free/subsidized nicotine replacement therapy (NRT), and municipality. * Statistically significant.
Unadjusted and adjusted logistic regression analysis of the effect (successful quitting) in the financial incentives municipalities (FIMs) compared with the campaign municipalities (CAMs) at the end of the intervention, and after 6 and 12+-months. The results are based on a complete case approach and stratified by socioeconomic status (SES). OR: odds ratio, CI: confidence interval.
| Unadjusted Analyses | Adjusted Analyses | |||||||
|---|---|---|---|---|---|---|---|---|
| Intervention | OR | [CI 95%] |
| OR | [CI 95%] |
| ||
| Low SES | ||||||||
| CAMs | 1.00 | |||||||
| FIMs (4–6 weeks) | 2.55 | [1.51, 4.30] | ≤0.001 | * | 2.89 | [1.31, 6.38] | 0.009 | * |
| FIMs (6 months) | 1.01 | [0.58, 1.76] | 0.963 | 0.72 | [0.29, 1.81] | 0.490 | ||
| FIMs (12+-months) | 0.80 | [0.43, 1.48] | 0.475 | 0.74 | [0.37, 1.46] | 0.381 | ||
| High SES | ||||||||
| CAMs | 1.00 | |||||||
| FIMs (4–6 weeks) | 2.41 | [1.37, 4.24] | 0.002 | * | 2.74 | [1.28, 5.84] | 0.009 | * |
| FIMs (6 months) | 1.50 | [0.93, 2.41] | 0.095 | 1.64 | [0.90, 2.98] | 0.107 | ||
| FIMs (12+-months) | 1.43 | [0.85, 2.43] | 0.179 | 1.53 | [0.87, 2.68] | 0.136 | ||
Adjusted analyses included age, sex, Fagerström score, number of cigarettes smoked daily, abstinence in 2017, proportion of smokers receiving free/subsidized nicotine replacement therapy (NRT), and municipality. * Statistically significant.